CHANGES IN BREAST CANCER TREATMENT MODALITIES IN THE LAST DECADE IN PUERTO RICO (MEETING ABSTRACT) NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


CHANGES IN BREAST CANCER TREATMENT MODALITIES IN THE LAST DECADE IN PUERTO RICO (MEETING ABSTRACT)

Proc Annu Meet Am Soc Clin Oncol; 11:A158 1992. Unique Identifier : AIDSLINE ICDB/92680889
Mora E; Romero H; Figueroa N; Lopez R; Dept. of Surgery, Univ. of Puerto Rico, San Juan, PR 00936

Abstract: The incidence and mortality rate of breast cancer in Puerto Rico has tripled in the last decade although both figures are significantly lower than those of the United States. In order to try to identify factors in the treatment modalities that may relate to the low mortality rate, we studied 2 groups of 85 patients (pts) treated in PR in 1983 and 1990, respectively. We compared these groups with respect to (1) frequency of use of medical and surgical modalities, (2) use of radiotherapy, (3) type of surgical and chemotherapeutic modalities used, and (4) incidence of recurrences. A table shows the frequency of surgical approaches used. There was (1) no significant difference in stage (S; S0-I 17%, SII 60%, SIII 15%, and SIV 7%), (2) no difference in the number of pts receiving either a single or a combination therapy, (3) a significant increase in breast-preserving procedures in 1990, (4) no change in the use of MRM and (5) no difference in the type of chemotherapeutic agents or amount of radiation administered. Even when there was a tendency toward a more conservative surgical approach, its use is still lower than in the US probably due to the low number of pts in early stages. There were no other changes in the treatment modalities that can explain the lower mortality rate in PR.
Keywords: Breast Neoplasms/DRUG THERAPY/RADIOTHERAPY/SURGERY/*THERAPY Combined Modality Therapy Human Mastectomy Puerto Rico Survival Analysis ABSTRACT

KWDbreastneoplasms/drugtherapy/radiotherapy/surgery/KWDtherapycombinedmodalitytherapyhumanmastectomypuertoricosurvivalanalysisabstract
921130
M92B0889

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .